Assignee
STEMBIOSYS INC
US·4 granted patents·4 pending applications·2 citations·filing 2015–2024
Top patents by PatentIndex Score
8 records- 0182US11220671B2Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compoundsSTEMBIOSYS INC·Filed 2020·Granted Jan 11, 2022·2 cites·9 claims
- 0275US2025066732A1Amniotic fluid cell-derived extracellular matrix and uses thereofSTEMBIOSYS INC·Filed 2024·Application pending·0 cites
- 0368US12270051B2Amniotic fluid cell-derived extracellular matrix and uses thereofSTEMBIOSYS INC·Filed 2021·Granted Apr 8, 2025·0 cites·16 claims
- 0468US11180732B2Amniotic fluid cell-derived extracellular matrix and uses thereofSTEMBIOSYS INC·Filed 2019·Granted Nov 23, 2021·0 cites·8 claims
- 0564US12454677B2Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compoundsSTEMBIOSYS INC·Filed 2021·Granted Oct 28, 2025·0 cites·19 claims
- 0656US2018200302A1Bone marrow stromal cell derived extracellular matrix protein extract and uses thereofSTEMBIOSYS INC·Filed 2018·Application pending·0 cites
- 0754US2017281686A1Bone marrow stromal cell derived extracellular matrix protein extract and uses thereofSTEMBIOSYS INC·Filed 2017·Application pending·0 cites
- 0838US2017335286A1Methods for maintaining and expanding mesenchymal stem cells on extracellular matrix coated microcarriersSTEMBIOSYS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →